Drug information for DEFINITY

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
INJECTABLE; INTRAVENOUS	6.52MG/ML	Prescription	(Reference Drug)	PERFLUTREN	Definity	LANTHEUS MEDCL	21064 2011-10-26 Letter 2011-10-25 Label 2008-06-05 Label 2008-05-14 Letter 2007-10-15 Letter 2007-10-10 Label 2007-10-04 Label 2004-06-02 Letter 2003-11-20 Other Important Information from FDA 2002-07-08 Letter 2002-02-21 Letter 2001-07-31 Letter 2001-07-31 Label 2001-07-31 Review

Drug Adverse Effects information for DEFINITY

Role code	Indications	Reaction	# Reports
PS	CHEST PAIN	ANXIETY	1
PS	CHEST PAIN	BACK PAIN	1
PS	CHEST PAIN	DYSARTHRIA	1
PS	CHEST PAIN	HEADACHE	1
PS	CHEST PAIN	NECK PAIN	1
PS	CHEST PAIN	TRANSIENT ISCHAEMIC ATTACK	1
PS	CHEST PAIN	VIITH NERVE PARALYSIS	1
PS	ECHOCARDIOGRAM	ATRIAL FIBRILLATION	2
PS	ECHOCARDIOGRAM	CARDIO-RESPIRATORY ARREST	1
PS	ECHOCARDIOGRAM	LOSS OF CONSCIOUSNESS	1
PS	ECHOCARDIOGRAM	OXYGEN SATURATION DECREASED	1
PS	ECHOCARDIOGRAM	PULSE ABSENT	1
PS	ECHOCARDIOGRAM	PULSELESS ELECTRICAL ACTIVITY	1
PS	ECHOCARDIOGRAM	TACHYCARDIA	1
PS	ECHOCARDIOGRAM	UNRESPONSIVE TO STIMULI	1
PS	STRESS ECHOCARDIOGRAM	ANXIETY	3
PS	STRESS ECHOCARDIOGRAM	BACK PAIN	3
PS	STRESS ECHOCARDIOGRAM	BLOOD PRESSURE DIASTOLIC DECREASED	1
PS	STRESS ECHOCARDIOGRAM	DYSARTHRIA	3
PS	STRESS ECHOCARDIOGRAM	HEADACHE	3
PS	STRESS ECHOCARDIOGRAM	HEART RATE DECREASED	1
PS	STRESS ECHOCARDIOGRAM	NECK PAIN	3
PS	STRESS ECHOCARDIOGRAM	TRANSIENT ISCHAEMIC ATTACK	3
PS	STRESS ECHOCARDIOGRAM	VIITH NERVE PARALYSIS	3

Ads by Google